There is no association between coffee consumption and an increased risk of atrial fibrillation, according to research published in the open access journal BMC Medicine. The research includes a meta-analysis of four other ...
Sep 22, 2015
0
158
A U.S. appeals court affirmed a ruling Wednesday that struck down one of the strictest anti-abortion laws in the country: a North Dakota law that bans abortions when a fetal heartbeat can be detected, which can be as early ...
Jul 22, 2015
0
10
Ireland's Health Department says doctors last year performed 26 abortions to protect women's lives, including on three women who had threatened to kill themselves if denied one.
Jun 29, 2015
0
6
Certain commonly prescribed anti-nausea medications given to patients during or after an operation could increase their risk of developing an irregular heartbeat, new research has found.
Jun 18, 2015
0
19
For the first time, scientists can efficiently generate large numbers of rare cells in the network that pushes the heart's chambers to consistently contract. The technique, published May 28 in Stem Cell Reports, could be ...
Jun 2, 2015
0
313
A federal appeals court struck down one of the nation's toughest abortion restrictions on Wednesday, agreeing with a lower court that ruled an Arkansas law unconstitutionally burdens women by banning abortions after the 12th ...
May 27, 2015
0
3
Chronic obstructive pulmonary disease, or COPD, is associated with increased risk of dying from a cardiovascular disease such as heart failure or a heart attack, as well as diseases not associated with the heart. However, ...
May 20, 2015
0
15
In research published today in the journal Cerebral Cortex, a team of scientists led by the University of Cambridge and the Medical Research Council (MRC) Cognition and Brain Sciences Unit, Cambridge, studied not only whether ...
Apr 20, 2015
0
158
(HealthDay)—Corlanor (ivabradine) has been approved by the U.S. Food and Drug Administration to treat chronic heart failure, the agency said in a news release.
Apr 17, 2015
0
3
Gilead Sciences said multiple Canadian provinces will provide access to the biotechnology company's hepatitis C drug Harvoni following a positive reimbursement recommendation from regulators.
Mar 24, 2015
0
3
